Call Back Request
  • Home
  • Calecim Professional Brand

Calecim Professional Brand

Brand Description

  • It’s no miracle. It’s Science.®

CALECIM® Professional is a revolutionary cosmeceutical, derived from over a decade of research in stem cell technology. All CALECIM® Professional skin care products are enhanced with CALECIM® rejuvenating conditioned media derived from advanced stem cell technology. This unique conditioned media helps restore the natural balance of the skin, leaving your skin looking and feeling fresh, radiant (giving it that glow that we all desire), and dramatically reducing the signs of ageing.

As we age, our skin regeneration becomes less effective due to reduced skin cell activity. This is when signs of ageing start to appear

With its highly potent, stem cell charged protein formulation, CALECIM® Professional helps create a biologically optimal environment for your skin cells to act younger, and even reverse the signs of ageing.

What is CALECIM®?

CALECIM®: Cord Lining Conditioned Media

CALECIM® is the collected protein mix derived from Cord Lining Cell culture and is classified as an Umbilical Extract. It is rich in proteins and growth factors responsible for tissue repair and regeneration. In high concentrations, these factors have significant, fast-acting anti-ageing benefits for the skin.

CALECIM® is different from other types of conditioned media as it is derived from high quality neonatal epithelial and mesenchymal stem cells. Daily treatment with CALECIM® results in clinically observed improvement in the appearance of fine lines, wrinkles, skin firmness and tone within the first 14 days of use (with optimal results in 90 days).

CALECIM® Professional Technology

The parent company of CALECIM®, CellResearch Corporation, is a biotechnology company that discovered the presence of stem cells in the umbilical cord lining in 2004. This is the richest source of epithelial and mesenchymal stem cells from a non-embryonic source. The company owns the intellectual property for Umbilical Cord Lining Stem Cells and maintains a strong focus on the medical applications of these cells. Patents in nearly 40 territories around the world have been granted for the discovery and therapeutic applications of these stem cells.

Umbilical cord lining stem cells have potential utility as a platform to treat a wide range of diseases, including those of the brain, heart, cornea, and skin. CellResearch Corporation is starting USFDA trials using Cord Lining Stem Cells to treat diabetic wounds.

CALECIM® is produced in ISO-certified laboratories owned by CellResearch Corporation. Stem cell proteins used in all CALECIM® products are of cosmetic cGMP grade with assured safety for use on intact skin.

Physician Statements

CALECIM® Professional is brand endorsed by Physicians and recognised by the medical society as a scientifically-proven stem cell technology; by adding our recommended statements from internationally renowned Physicians, you will promote the CALECIM® Professional efficacy and consistent quality.

CALECIM® Professional integration with Physicians’ aesthetic treatments has given Physicians higher patient satisfaction, clinic revenue and repeat purchase of CALECIM® Professional products.

Should your market allow Physicians’ testimonials, we strongly suggest you leverage on international and/or local testimonials along with photos of Physicians.

Example of Physician’s quote:


“I have just concluded a four-week trial using CALECIM® Multi Action Cream, and
have been quite impressed with the changes in my patients’ skin, even after only
two weeks of use.

In addition to an improved overall complexion, I have observed increased skin
tone and skin fullness resulting in a lifting effect, a tighter jawline, elevated
eyebrows, and enhanced facial definition.

Our results have been consistent across a range of skin types and patient ages,
with high patient satisfaction.

In fact, most of the patients have asked to continue using the CALECIM® Multi
Action Cream even after the trial formally ended.”

Dr Ziv Peled, MD, San Francisco